Institute of Biomedicine - News

A recent study from the Institute of Biomedicine at the University of Eastern Finland shows that the glucocorticoid receptor can both promote and inhibit prostate cancer progression, depending on the circumstances.

The awarded research focused on adipose tissue-derived extracellular vesicles.

The results provide a comprehensive integrated analysis of multiple genome-wide analysis methods that improves the understanding on how genetic variation is linked to the different layers of gene regulation in a model for polygenic disease.

The textbook explains how nutrition has shaped human evolution and its consequences for our susceptibility to diseases like diabetes and atherosclerosis.

The doctoral research led to the development new methods, designed to advance the discovery of disease subtypes and facilitate targeted drug development.

Found in the Finnish population, a rare variant of the TYROBP gene significantly increases the risk of Alzheimer’s disease, a new study led by the University of Eastern Finland shows.

Research conducted with zebrafish can contribute to personalised medicine approaches, including the selection of the most individually suitable treatments for patients with cancer.

The method, called KMAP, enables intuitive visualisation of short DNA sequences and helps reveal how regulatory elements behave in different biological contexts.

Entrepreneurial skill-building, career transitions from academia to industry, and the future of research and innovation in neuroscience were key topics at Neurocenter Finland’s Annual Event.

A recent Finnish study suggests that limiting screen time and promoting physical activity from childhood may help safeguard mental health in adolescence.